- Home
- STSS vs CERO Comparison
STSS vs CERO Comparison
Compare STSS & CERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STSS
- CERO
- Stock Information
- Founded
- STSS 2017
- CERO 2017
- Country
- STSS United States
- CERO United States
- Employees
- STSS N/A
- CERO N/A
- Industry
- STSS Medical/Dental Instruments
- CERO
- Sector
- STSS Health Care
- CERO
- Exchange
- STSS Nasdaq
- CERO Nasdaq
- Market Cap
- STSS 3.3M
- CERO 3.1M
- IPO Year
- STSS 2022
- CERO N/A
- Fundamental
- Price
- STSS $0.02
- CERO $0.89
- Analyst Decision
- STSS
- CERO Strong Buy
- Analyst Count
- STSS 0
- CERO 1
- Target Price
- STSS N/A
- CERO $11.00
- AVG Volume (30 Days)
- STSS 282.3M
- CERO 4.4M
- Earning Date
- STSS 05-13-2025
- CERO 04-15-2025
- Dividend Yield
- STSS N/A
- CERO N/A
- EPS Growth
- STSS N/A
- CERO N/A
- EPS
- STSS N/A
- CERO N/A
- Revenue
- STSS N/A
- CERO N/A
- Revenue This Year
- STSS N/A
- CERO N/A
- Revenue Next Year
- STSS N/A
- CERO N/A
- P/E Ratio
- STSS N/A
- CERO N/A
- Revenue Growth
- STSS N/A
- CERO N/A
- 52 Week Low
- STSS $0.01
- CERO $0.53
- 52 Week High
- STSS $18.15
- CERO $171.00
- Technical
- Relative Strength Index (RSI)
- STSS 29.62
- CERO 49.91
- Support Level
- STSS $0.02
- CERO $0.53
- Resistance Level
- STSS $0.04
- CERO $1.42
- Average True Range (ATR)
- STSS 0.01
- CERO 0.12
- MACD
- STSS 0.02
- CERO 0.07
- Stochastic Oscillator
- STSS 22.20
- CERO 40.19
About STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes are designed to eliminate potentially infectious and accidental needlestick injuries.
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.